From a Company Update "NeuroLens" Issued TODAY
FDA Clinical Hold
Following our most recent official update via the ASX platform and investor webinar, we have been actively engaging with the FDA to seek confirmation of next steps required to lift the clinical hold on NUZ-001. These discussions have been constructive, and we are working diligently to address the necessary considerations. We will provide further updates as developments materialise. (Text highlighting added by me)
Ann: Neurizon updates on NUZ-001 IND Application, page-359
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $86.15M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 16.5¢ | $91.76K | 527.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 80407 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 31 | 1 |
View Market Depth
| Last trade - 15.34pm 20/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |